drug

methocarbamol

Marketedupdated 2mo ago

by Beximco Pharmaceuticals USA Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Patent cliff

source: FDA Orange Book

first barrier falls

Oct 9, 2044

~18.3 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (1)

Oct 9, 2044formulationUS 12390439

Data sources

ClinicalTrials.gov

last refreshed 10m ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 2

Trials studying methocarbamol

phase3A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacementcompletedn=151